In This Section

AACR Team Science Award

Nomination StatusClosed
Nomination DeadlineSeptember 30, 2021
Description

The AACR Team Science Award was established by the American Association for Cancer Research and Eli Lilly and Company to acknowledge and catalyze the growing importance of interdisciplinary teams to the understanding of cancer and/or the translation of research discoveries into clinical cancer applications.

This Award recognizes an outstanding interdisciplinary research team for their innovative and meritorious science that has advanced or may advance our fundamental knowledge of cancer, or a team that has applied existing knowledge to advancing the detection, diagnosis, prevention, or treatment of cancer.

Eligibility Criteria

Cancer researchers affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may be nominated. Such institutions include those in academia, industry, or government.

Institutions and/or organizations are not eligible to receive the Award.

Eligible teams may be comprised of independent faculty-level researchers providing complementary interdisciplinary expertise, each of whom have made separate substantive and quantifiable contributions to the research being recognized.

Team members may be working within the same institution or at several institutions. However, if researchers are employed at the same institution, they must possess separate funding and research space.

The team research being recognized should reflect work focused on a specific scientific goal that otherwise would not be realized by any single component of the team.

Teams comprising academic and industry researchers will be accepted.

Contact Information

Please direct all inquiries pertaining to this Award or any other AACR scientific achievement award or lecture to Michael J. Powell, PhD, Deputy Director of Scientific Programs, at [email protected] or by phone at (215) 440-9373.

Nomination Criteria

Nominations may be submitted by any individual, whether an AACR member or nonmember, who is currently or has previously been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science.

Self-nominations are prohibited.

Nominators must maintain strict confidentiality of their nominations and all nominations must be submitted electronically to https://myaacr.aacr.org. Paper nominations will not be accepted.

Eligible nominations must include the following:

A nomination letter written in English (Max: 1,000 words), which comprehensively describes the candidate team’s novel and significant work that has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of cancer. Letter must specifically outline the team’s current research activity and indicate how their collective research holds promise for continued substantive contributions to the cancer field. All publications that directly support the mentioned research accomplishments must be referenced within the provided letter.

  • A brief scientific citation (Max: 50 words) highlighting the major scientific contribution(s) justifying the team’s nomination.
  • A comprehensive listing of all team members that includes professional title(s), affiliation(s), primary research area(s), and a brief description of each member’s substantive and quantifiable contribution(s) to the team.

See the Program Guidelines and Nomination Instructions for complete details.

Selection Process

Eligible nominees will be considered by an Award Selection Committee composed of an international cohort of cancer research experts appointed by the AACR President. After Award Committee deliberations, primary and alternate award recipient recommendations will be relayed to the AACR Executive Committee for formal ratification.

Selection of the Award recipient shall be made on the basis of the candidate's scientific accomplishments without regard to race, gender, nationality, geographic location, or religious or political views.